eIF2γ has a catalytic site for GTPase activity and is involved in binding of the ternary complex to mRNA; the eIF2γ variant is associated with hypothalamo-pituitary development, hypopituitarism, and pancreatic dysfunction and glucose regulation [16]. The gene discussed is EIF2S3; the disease is hypopituitarism.